KR100554860B1 - 미백 화장품 재료 - Google Patents
미백 화장품 재료 Download PDFInfo
- Publication number
- KR100554860B1 KR100554860B1 KR1019997011602A KR19997011602A KR100554860B1 KR 100554860 B1 KR100554860 B1 KR 100554860B1 KR 1019997011602 A KR1019997011602 A KR 1019997011602A KR 19997011602 A KR19997011602 A KR 19997011602A KR 100554860 B1 KR100554860 B1 KR 100554860B1
- Authority
- KR
- South Korea
- Prior art keywords
- salts
- linoleate
- collagen
- unsaturated fatty
- acid
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 58
- 206010040829 Skin discolouration Diseases 0.000 title 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims abstract description 56
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims abstract description 56
- 239000000463 material Substances 0.000 claims abstract description 55
- 150000003839 salts Chemical class 0.000 claims abstract description 42
- 230000002087 whitening effect Effects 0.000 claims abstract description 36
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 31
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 23
- 229920002683 Glycosaminoglycan Polymers 0.000 claims abstract description 19
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 7
- 239000008406 cosmetic ingredient Substances 0.000 claims abstract description 6
- 239000002502 liposome Substances 0.000 claims description 59
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 39
- 235000020778 linoleic acid Nutrition 0.000 claims description 29
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 29
- 108010035532 Collagen Proteins 0.000 claims description 28
- 102000008186 Collagen Human genes 0.000 claims description 28
- 229920001436 collagen Polymers 0.000 claims description 28
- -1 amino acid salts Chemical class 0.000 claims description 27
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 26
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 18
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 14
- 229940049918 linoleate Drugs 0.000 claims description 14
- 239000011734 sodium Substances 0.000 claims description 14
- 229910052708 sodium Inorganic materials 0.000 claims description 14
- 239000007864 aqueous solution Substances 0.000 claims description 13
- 239000005018 casein Substances 0.000 claims description 12
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 12
- 235000021240 caseins Nutrition 0.000 claims description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 11
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 10
- 229960004488 linolenic acid Drugs 0.000 claims description 10
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 claims description 9
- 108010076119 Caseins Proteins 0.000 claims description 8
- 102000016942 Elastin Human genes 0.000 claims description 8
- 108010014258 Elastin Proteins 0.000 claims description 8
- 150000005690 diesters Chemical class 0.000 claims description 8
- 229920002549 elastin Polymers 0.000 claims description 8
- 229910052751 metal Inorganic materials 0.000 claims description 8
- 239000002184 metal Substances 0.000 claims description 8
- 102000011782 Keratins Human genes 0.000 claims description 6
- 108010076876 Keratins Proteins 0.000 claims description 6
- 108010045569 atelocollagen Proteins 0.000 claims description 6
- 159000000001 potassium salts Chemical class 0.000 claims description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 5
- 102000011632 Caseins Human genes 0.000 claims description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 claims description 5
- 229940031016 ethyl linoleate Drugs 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 229920002674 hyaluronan Polymers 0.000 claims description 5
- 229960003160 hyaluronic acid Drugs 0.000 claims description 5
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 claims description 5
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 4
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 4
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 4
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 4
- 150000004665 fatty acids Chemical class 0.000 claims description 4
- UAERWSVCVIITFA-ISKARVOYSA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;(9z,12z)-octadeca-9,12-dienoic acid Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N.CCCCC\C=C/C\C=C/CCCCCCCC(O)=O UAERWSVCVIITFA-ISKARVOYSA-N 0.000 claims description 3
- WECGLUPZRHILCT-GSNKCQISSA-N 1-linoleoyl-sn-glycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC[C@@H](O)CO WECGLUPZRHILCT-GSNKCQISSA-N 0.000 claims description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims description 3
- WXXOHSFUHUTFKS-NBTZWHCOSA-N 2-[bis(2-hydroxyethyl)amino]ethanol;(9z,12z)-octadeca-9,12-dienoic acid Chemical compound OCCN(CCO)CCO.CCCCC\C=C/C\C=C/CCCCCCCC(O)=O WXXOHSFUHUTFKS-NBTZWHCOSA-N 0.000 claims description 3
- 229920000045 Dermatan sulfate Polymers 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 229940051593 dermatan sulfate Drugs 0.000 claims description 3
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229920001282 polysaccharide Polymers 0.000 claims description 3
- 239000005017 polysaccharide Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- WYPBVHPKMJYUEO-NBTZWHCOSA-M sodium;(9z,12z)-octadeca-9,12-dienoate Chemical compound [Na+].CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O WYPBVHPKMJYUEO-NBTZWHCOSA-M 0.000 claims description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 2
- 229920002971 Heparan sulfate Polymers 0.000 claims description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 229920000669 heparin Polymers 0.000 claims description 2
- 229960002897 heparin Drugs 0.000 claims description 2
- 229940099578 hydrogenated soybean lecithin Drugs 0.000 claims description 2
- 229940083466 soybean lecithin Drugs 0.000 claims description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 2
- 230000019612 pigmentation Effects 0.000 abstract description 24
- 102000004169 proteins and genes Human genes 0.000 abstract description 16
- 108090000623 proteins and genes Proteins 0.000 abstract description 16
- 239000004480 active ingredient Substances 0.000 abstract description 6
- 239000008213 purified water Substances 0.000 description 29
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 28
- 208000012641 Pigmentation disease Diseases 0.000 description 28
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical class [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 27
- 150000002148 esters Chemical class 0.000 description 22
- 239000000203 mixture Substances 0.000 description 22
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 21
- 238000000034 method Methods 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 18
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- 235000006708 antioxidants Nutrition 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical class [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 229930003427 Vitamin E Natural products 0.000 description 14
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 14
- 235000018102 proteins Nutrition 0.000 description 14
- 239000011709 vitamin E Substances 0.000 description 14
- 235000019165 vitamin E Nutrition 0.000 description 14
- 229940046009 vitamin E Drugs 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 13
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000000284 extract Substances 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical compound OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 9
- 239000000787 lecithin Substances 0.000 description 9
- 235000010445 lecithin Nutrition 0.000 description 9
- 229940058015 1,3-butylene glycol Drugs 0.000 description 8
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 8
- 229920002125 Sokalan® Polymers 0.000 description 8
- 235000019437 butane-1,3-diol Nutrition 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 8
- 229940067606 lecithin Drugs 0.000 description 8
- 238000010979 pH adjustment Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 150000005846 sugar alcohols Polymers 0.000 description 8
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 239000003002 pH adjusting agent Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 108010009736 Protein Hydrolysates Proteins 0.000 description 6
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 239000007857 degradation product Substances 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 239000008240 homogeneous mixture Substances 0.000 description 6
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 235000021355 Stearic acid Nutrition 0.000 description 5
- 238000001816 cooling Methods 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 5
- 239000008117 stearic acid Substances 0.000 description 5
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 4
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 239000006096 absorbing agent Substances 0.000 description 4
- 239000000783 alginic acid Substances 0.000 description 4
- 235000010443 alginic acid Nutrition 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 229960001126 alginic acid Drugs 0.000 description 4
- 150000004781 alginic acids Chemical class 0.000 description 4
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 239000004310 lactic acid Chemical class 0.000 description 4
- 235000014655 lactic acid Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 239000008347 soybean phospholipid Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 229940121363 anti-inflammatory agent Drugs 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 238000004061 bleaching Methods 0.000 description 3
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 3
- 229940090949 docosahexaenoic acid Drugs 0.000 description 3
- 239000000686 essence Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 231100000245 skin permeability Toxicity 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- 241000208690 Hamamelis Species 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229920002385 Sodium hyaluronate Polymers 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000000481 effect on pigmentation Effects 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000010350 erythorbic acid Nutrition 0.000 description 2
- 239000004318 erythorbic acid Substances 0.000 description 2
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 2
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 2
- 229960002733 gamolenic acid Drugs 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 229940026239 isoascorbic acid Drugs 0.000 description 2
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 2
- 229960004705 kojic acid Drugs 0.000 description 2
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 229960004232 linoleic acid Drugs 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 2
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 2
- 230000003169 placental effect Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000002861 polymer material Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 239000003223 protective agent Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 229940010747 sodium hyaluronate Drugs 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- DEQUKPCANKRTPZ-UHFFFAOYSA-N (2,3-dihydroxyphenyl)-phenylmethanone Chemical compound OC1=CC=CC(C(=O)C=2C=CC=CC=2)=C1O DEQUKPCANKRTPZ-UHFFFAOYSA-N 0.000 description 1
- FBZQBGYPONNWCG-UHFFFAOYSA-N (4,5-dihydroxy-2,3-dimethoxyphenyl)-phenylmethanone Chemical compound COC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1OC FBZQBGYPONNWCG-UHFFFAOYSA-N 0.000 description 1
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 1
- RQOACSXXXITALU-UHFFFAOYSA-N 1,4-dimethyl-7-propan-2-ylazulene-2-sulfonic acid Chemical class CC(C)C1=CC=C(C)C2=CC(S(O)(=O)=O)=C(C)C2=C1 RQOACSXXXITALU-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- KNUPSOXBESCJLY-UHFFFAOYSA-N 2-methoxy-1-phenylhexan-1-one Chemical compound CCCCC(OC)C(=O)C1=CC=CC=C1 KNUPSOXBESCJLY-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-UHFFFAOYSA-N 5-oxoproline Chemical compound OC(=O)C1CCC(=O)N1 ODHCTXKNWHHXJC-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241000244355 Ligusticum Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 1
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940051810 licorice root extract Drugs 0.000 description 1
- 235000020725 licorice root extract Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- PVWXTVUZGJXFJQ-UHFFFAOYSA-N methyl 4-methyl-3-phenyl-2-propan-2-ylpent-2-enoate Chemical compound COC(=O)C(C(C)C)=C(C(C)C)C1=CC=CC=C1 PVWXTVUZGJXFJQ-UHFFFAOYSA-N 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 229960001173 oxybenzone Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- LYKRPDCJKSXAHS-UHFFFAOYSA-N phenyl-(2,3,4,5-tetrahydroxyphenyl)methanone Chemical compound OC1=C(O)C(O)=CC(C(=O)C=2C=CC=CC=2)=C1O LYKRPDCJKSXAHS-UHFFFAOYSA-N 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229940037001 sodium edetate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- ZXHXYXSTAYNRLQ-DWJAGBRCSA-K tripotassium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4, Chemical compound [K+].[K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C([O-])=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O ZXHXYXSTAYNRLQ-DWJAGBRCSA-K 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A61K8/553—Phospholipids, e.g. lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims (10)
- (A) 탄소수가 18 내지 22이고 분자 구조내 이중결합 수가 2 내지 6인 불포화 지방산 및 당해 불포화 지방산의 금속 염, 아미노산 염, 아민 염, 모노-에스테르 및 디-에스테르로부터 선택된 하나 이상의 성분,(B) 인지질,(C) 산화방지제,(D) 콜라겐, 엘라스틴, 케라틴, 카제인, 가수분해된 콜라겐, 아텔로콜라겐, 가수분해된 나트륨 카제인, 가수분해된 에틸 콜라겐 및 수용성 콜라겐으로부터 선택된 하나 이상의 성분 및(E) 뮤코폴리사카라이드(muco-polysaccharide) 및 이의 나트륨 염 및 칼륨 염으로부터 선택된 하나 이상의 성분을 포함하는 미백 화장품 재료.
- (A) 탄소수가 18 내지 22이고 분자 구조내 이중결합 수가 2 내지 6인 불포화 지방산 및 당해 불포화 지방산의 금속 염, 아미노산 염, 아민 염, 모노-에스테르 및 디-에스테르로부터 선택된 하나 이상의 성분,(B) 인지질,(C) 산화방지제,(D) 콜라겐, 엘라스틴, 케라틴, 카제인, 가수분해된 콜라겐, 아텔로콜라겐, 가수분해된 나트륨 카제인, 가수분해된 에틸 콜라겐 및 수용성 콜라겐으로부터 선택된 하나 이상의 성분 및(E) 뮤코폴리사카라이드 및 이의 나트륨 염 및 칼륨 염으로부터 선택된 하나 이상의 성분을 함유하는 리포좀성 복합체를 포함하는 미백 화장품 재료.
- 제1항 또는 제2항에 있어서, 인지질이 대두 레시틴, 난황 레시틴, 수소화된 대두 레시틴 및 수소화된 난황 레시틴으로부터 선택된 하나 이상의 성분인 미백 화 장품 재료.
- 삭제
- 제1항 또는 제2항에 있어서, 뮤코폴리사카라이드가 콘드로이틴 설페이트, 하이알루론산, 더마탄 설페이트, 헤파란 설페이트, 뮤코이틴 설페이트, 헤파린, 및 이들의 나트륨 염 및 칼륨 염으로부터 선택된 하나 이상의 성분인 미백 화장품 재료.
- 제1항 또는 제2항에 있어서, 불포화 지방산 및 당해 불포화 지방산의 금속 염, 아미노산 염, 아민 염, 모노-에스테르 및 디-에스테르의 양이 화장품 재료의 총량의 0.01 내지 0.7중량%인 미백 화장품 재료.
- 제2항에 있어서, 리포좀성 복합체가, (A) 탄소수가 18 내지 22이고 분자 구조내 이중결합 수가 2 내지 6인 불포화 지방산 및 당해 불포화 지방산의 금속 염, 아미노산 염, 아민 염, 모노-에스테르 및 디-에스테르로부터 선택된 하나 이상의 성분, (B) 인지질 및 (C) 산화방지제를 물 중에서 혼합하여 리포좀을 형성시킨 다음, 생성된 리포좀을 (D) 콜라겐, 엘라스틴, 케라틴, 카제인, 가수분해된 콜라겐, 아텔로콜라겐, 가수분해된 나트륨 카제인, 가수분해된 에틸 콜라겐 및 수용성 콜라겐으로부터 선택된 하나 이상의 성분 및 (E) 뮤코폴리사카라이드 및 이의 나트륨 염 및 칼륨 염으로부터 선택된 하나 이상의 성분을 함유하는 수용액과 혼합시켜 제조되는 미백 화장품 재료.
- 제2항에 있어서, 리포좀성 복합체가, (D) 콜라겐, 엘라스틴, 케라틴, 카제인, 가수분해된 콜라겐, 아텔로콜라겐, 가수분해된 나트륨 카제인, 가수분해된 에틸 콜라겐 및 수용성 콜라겐으로부터 선택된 하나 이상의 성분 및 (E) 뮤코폴리사카라이드 및 이의 나트륨 염 및 칼륨 염으로부터 선택된 하나 이상의 성분을 함유하는 수용액 중에서, (A) 탄소수가 18 내지 22이고 분자 구조내 이중결합 수가 2 내지 6인 불포화 지방산 및 당해 불포화 지방산의 금속 염, 아미노산 염, 아민 염, 모노-에스테르 및 디-에스테르로부터 선택된 하나 이상의 성분, (B) 인지질 및 (C) 산화방지제를 포함하는 리포좀을 형성시켜 제조되는 미백 화장품 재료.
- 제1항, 제2항, 제7항 또는 제8항에 있어서, 불포화 지방산의 금속 염, 아미노산 염, 아민 염, 모노-에스테르 및 디-에스테르가 나트륨 리놀레에이트, 칼륨 α-리놀레네이트, 아르기닌 리놀레에이트, 리신 α-리놀레네이트, 트리에탄올아민 리놀레에이트, 모노에탄올아민 α-리놀레네이트, 에틸 리놀레에이트, 에틸 α-리놀레네이트, 리놀레산 모노글리세라이드, α-리놀렌산 모노글리세라이드, 리놀레산 디글리세라이드 또는 α-리놀렌산 디글리세라이드인 미백 화장품 재료.
- 제6항에 있어서, 불포화 지방산의 금속 염, 아미노산 염, 아민 염, 모노-에스테르 및 디-에스테르가 나트륨 리놀레에이트, 칼륨 α-리놀레네이트, 아르기닌 리놀레에이트, 리신 α-리놀레네이트, 트리에탄올아민 리놀레에이트, 모노에탄올아민 α-리놀레네이트, 에틸 리놀레에이트, 에틸 α-리놀레네이트, 리놀레산 모노글리세라이드, α-리놀렌산 모노글리세라이드, 리놀레산 디글리세라이드 또는 α-리놀렌산 디글리세라이드인 미백 화장품 재료.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9/169590 | 1997-06-10 | ||
JP16959097A JP3687277B2 (ja) | 1997-06-10 | 1997-06-10 | 美白化粧料 |
PCT/JP1998/002548 WO1998056338A1 (fr) | 1997-06-10 | 1998-06-09 | Produit cosmetique eclaircissant la peau |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010013593A KR20010013593A (ko) | 2001-02-26 |
KR100554860B1 true KR100554860B1 (ko) | 2006-02-24 |
Family
ID=15889316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019997011602A KR100554860B1 (ko) | 1997-06-10 | 1998-06-09 | 미백 화장품 재료 |
Country Status (9)
Country | Link |
---|---|
US (1) | US6669932B2 (ko) |
EP (1) | EP0992236B1 (ko) |
JP (1) | JP3687277B2 (ko) |
KR (1) | KR100554860B1 (ko) |
CN (1) | CN1125634C (ko) |
DE (1) | DE69812948T2 (ko) |
HK (1) | HK1026376A1 (ko) |
TW (1) | TW381028B (ko) |
WO (1) | WO1998056338A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101607166B1 (ko) * | 2008-10-01 | 2016-03-29 | (주)아모레퍼시픽 | 포스파티딜에탄올아민과 포스파티딜콜린을 포함한 리포좀을함유하는 피부 미백용 화장료 조성물 |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4894532A (en) * | 1988-03-28 | 1990-01-16 | Westinghouse Electric Corp. | Optical fiber sensor with light absorbing moisture-sensitive coating |
US6287579B1 (en) * | 1999-06-11 | 2001-09-11 | International Flora Technologies, Ltd | Oxidatively stable long-chain ethyl ester emollients |
MXPA02007822A (es) * | 2000-02-25 | 2004-09-10 | Kuhs Kosmetik Gmbh & Co Kg | Composicion cosmetica, especialmente para el uso en piel envejecida y/o tensa. |
US6881427B2 (en) * | 2002-01-31 | 2005-04-19 | Alticor Inc. | Topical anti-inflammatory composition containing linseed and licorice extracts |
KR20030065965A (ko) * | 2002-02-02 | 2003-08-09 | 주식회사 두산 | 리소포스파티딜에탄올아민을 유효성분으로 함유하는 피부미백용 조성물 |
JP3802011B2 (ja) * | 2003-06-16 | 2006-07-26 | 有限会社 シーバイオン | 美白剤 |
JP4653513B2 (ja) * | 2004-02-25 | 2011-03-16 | 株式会社コーセー | 皮膚外用剤 |
FR2870741B1 (fr) * | 2004-05-25 | 2008-03-14 | Coletica Sa | Phase lamellaires hydratees ou liposomes, contenant une monoamine grasse ou un polymere cationique favorisant la penetration intercellulaire, et composition cosmetique ou pharmaceutique la contenant. |
JP2007320851A (ja) * | 2004-09-10 | 2007-12-13 | Kose Corp | 皮膚外用剤 |
JP5093998B2 (ja) * | 2004-09-22 | 2012-12-12 | 大塚製薬株式会社 | 色素沈着予防又は改善剤 |
CA2599112C (en) | 2005-02-14 | 2013-10-22 | Suntory Limited | Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient |
FI20050453A0 (fi) | 2005-04-29 | 2005-04-29 | Aromtech Ltd | Ihonhoitokoostumus |
CN1742623A (zh) * | 2005-07-13 | 2006-03-08 | 凌沛学 | 透明质酸磷脂复合物及其制备方法 |
EP1951762B1 (en) * | 2005-10-03 | 2018-02-07 | PINSKY, Mark A. | Compositions and methods for improved skin care |
JP2007126444A (ja) * | 2005-10-03 | 2007-05-24 | Kose Corp | 皮膚外用剤 |
US8518445B2 (en) * | 2006-01-20 | 2013-08-27 | Research Foundation Of The City University Of New York | Changing skin-color perception using quantum and optical principles in cosmetic preparations |
JP2007314427A (ja) * | 2006-05-23 | 2007-12-06 | Nippon Fine Chem Co Ltd | リポ酸含有複合体 |
JP2008094809A (ja) * | 2006-10-16 | 2008-04-24 | Kose Corp | リポソーム組成物およびそれを配合する化粧料、並びに皮膚外用剤 |
US20100104673A1 (en) | 2006-10-24 | 2010-04-29 | Jormay, Inc. | Methods and Compositions for Treatment of Skin Conditions |
KR100824212B1 (ko) * | 2006-11-03 | 2008-04-24 | 김윤범 | 태반을 함유하는 피부보호용 조성물 및 그의 제조방법 |
FR2909554B1 (fr) * | 2006-12-08 | 2013-11-01 | Biorecept Lab | Composition cosmetique anti-rides comprenant de l'acide hyaluronique |
KR100753437B1 (ko) | 2007-01-17 | 2007-09-14 | (주)미시앙 | 홍삼 조사포닌과 감초,비오틴(Biotin),쿠퍼 펩타이드(Copper peptide), 사이토카인(Cytokines)을 함유한 나노 리포좀 입자 및 이를 함유한 헤어 케어용 화장료 |
US9657257B2 (en) * | 2007-05-10 | 2017-05-23 | Kimberly-Clark Worldwide, Inc. | Colorant neutralizer |
US20080276379A1 (en) * | 2007-05-10 | 2008-11-13 | Macdonald John Gavin | Methods for discharging colorants |
US20090062764A1 (en) * | 2007-08-30 | 2009-03-05 | Kimberly-Clark Worldwide, Inc. | Zoned application of decolorizing composition for use in absorbent articles |
KR100924643B1 (ko) * | 2007-10-12 | 2009-11-02 | 세원셀론텍(주) | 아텔로콜라겐을 포집한 리포좀의 제조방법 |
EP2222270B1 (en) | 2007-12-26 | 2018-11-14 | Mark A. Pinsky | Collagen formulations for improved skin care |
IL191123A0 (en) * | 2008-04-28 | 2009-02-11 | Meir Shinitzky | Composition comprising phospholipids in combination with ascorbic acid and cosmetic products comprising it |
DE102008032327A1 (de) * | 2008-07-09 | 2010-01-14 | Rovi Cosmetics International Gmbh | Kosmetisches oder pharmazeutisches Präparat zur topischen Applikation von mehrfach ungesättigten Fettsäuren |
JP2010120860A (ja) * | 2008-11-17 | 2010-06-03 | Nippon Menaade Keshohin Kk | 美白剤 |
PT2346573E (pt) * | 2008-11-20 | 2014-09-25 | Derivati Organici Lab | Utilização de sulfato de heparano em preparações cosméticas e dermatológicas |
WO2010077165A1 (en) * | 2008-12-31 | 2010-07-08 | Obschestvo S Ogranichennoi Otvetstvennostju Scientific Company Flamena | Phospholipid emulsion containing dihydroquercetin, and method of producing thereof |
JP5951173B2 (ja) * | 2009-01-09 | 2016-07-13 | ロート製薬株式会社 | ジフェンヒドラミン又はその塩並びにアスコルビン酸又はその塩を含有する外用組成物の変色抑制方法 |
DE102009029194A1 (de) | 2009-09-04 | 2011-04-07 | Kimberly-Clark Worldwide, Inc., Neenah | Abtrennung gefärbter Stoffe aus wasserhaltigen Flüssigkeiten |
JP5695308B2 (ja) * | 2009-10-02 | 2015-04-01 | 株式会社フェース | コラーゲン修飾リポソームからなる化粧料基剤およびそれを含有する皮膚化粧料 |
JP5756602B2 (ja) * | 2010-04-16 | 2015-07-29 | 株式会社フェース | ゼラチンおよび/またはエラスチン構成ポリペプチドで修飾されたリポソームからなる化粧料基剤およびそれを含有する皮膚化粧料 |
FR2962044B1 (fr) * | 2010-04-21 | 2013-02-22 | Horus Pharma | Emulsion lacrymimetique |
KR101796694B1 (ko) * | 2010-11-30 | 2017-11-13 | (주)아모레퍼시픽 | 피부 미백 및 탄력 제고 화장료 조성물 |
SG10201602752XA (en) * | 2011-01-07 | 2016-05-30 | Allergan Inc | Melanin modification compositions and methods of use |
CA2825417A1 (en) * | 2011-01-25 | 2012-08-02 | The Procter And Gamble Company | Liposome and personal care composition comprising thereof |
KR101771063B1 (ko) | 2011-01-27 | 2017-08-24 | 선스타 가부시키가이샤 | 다가 불포화 지방산 함유 조성물 |
TW201334803A (zh) * | 2012-02-20 | 2013-09-01 | Taiwan Sugar Corp | 肝素用於皮膚保濕與美白及防止皮膚老化之新穎用途 |
US9283127B2 (en) | 2012-03-30 | 2016-03-15 | Kimberly-Clark Worldwide, Inc. | Absorbent articles with decolorizing structures |
CN104411296A (zh) * | 2012-05-16 | 2015-03-11 | 考希德芭以奧帕有限公司 | 含有鱼类眼球的粉碎物或提取物的化妆料、药学及食品组合物 |
US9441051B2 (en) * | 2012-11-26 | 2016-09-13 | Albert Ludwigs Universitäfreiburg | Matrices comprising modified polysaccharides and modified polysaccharides |
US9511144B2 (en) | 2013-03-14 | 2016-12-06 | The Proctor & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
US9237975B2 (en) | 2013-09-27 | 2016-01-19 | Kimberly-Clark Worldwide, Inc. | Absorbent article with side barriers and decolorizing agents |
CN104042547B (zh) * | 2014-06-16 | 2015-09-16 | 诺斯贝尔(中山)无纺日化有限公司 | 一种含卵磷脂的美白保湿天丝面膜液 |
CN107405282B (zh) * | 2015-03-02 | 2021-01-08 | 株式会社爱茉莉太平洋 | 含有皮肤脂质成分的纳米多层脂质体及其制备方法 |
CN105726348B (zh) * | 2016-02-23 | 2018-10-02 | 付涛 | 化妆品用组合物 |
CA3056759C (en) | 2016-03-22 | 2024-01-23 | Avicenna Nutraceutical, Llc | Hydrolyzed collagen compositions and methods of making thereof |
JP6169240B1 (ja) * | 2016-10-28 | 2017-07-26 | サンスター株式会社 | リノール酸含有組成物 |
CN107551390A (zh) * | 2017-08-21 | 2018-01-09 | 常熟佳禾生物科技有限公司 | 一种用于治疗乳腺小叶增生的中药文胸贴片及其制备方法 |
CN107569436B (zh) * | 2017-09-26 | 2020-12-15 | 北京斯利安药业有限公司 | 一种护肤组合物、柔肤水及其制备方法 |
DE102018201598A1 (de) * | 2018-02-02 | 2019-08-08 | Beiersdorf Ag | Stabile Wundheilsalbe |
JP7158922B2 (ja) * | 2018-06-29 | 2022-10-24 | サンスター株式会社 | リノール酸を含有する組成物 |
WO2020137017A1 (ja) * | 2018-12-26 | 2020-07-02 | 日本精化株式会社 | 美白剤、ヒアルロン酸産生促進剤、コラーゲン産生促進剤、細胞内活性酸素消去剤、刺激緩和剤、シワ改善剤、複合体、化粧料、及び皮膚外用剤 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8327330D0 (en) * | 1983-10-12 | 1983-11-16 | Parsons W J | Membrane analogue emulsions |
CA1257200A (en) * | 1984-03-07 | 1989-07-11 | Roshdy Ismail | Agents for the treatment and protection of the skin |
FR2609630B1 (fr) | 1987-01-19 | 1991-01-04 | Rochas Parfums | Nouvelles compositions cosmetiques ou dermatologiques renfermant un extrait des fruits de silybum marianum riche en silymarine associe a des acides gras essentiels |
US5279834A (en) * | 1987-06-12 | 1994-01-18 | Lvmh Recherche | Pharmaceutical or cosmetic composition containing hydroquinone and kojic acid |
JP2614474B2 (ja) * | 1988-01-20 | 1997-05-28 | サンスター株式会社 | 美白化粧料 |
JP2553474B2 (ja) * | 1988-09-29 | 1996-11-13 | 鐘紡株式会社 | 皮膚化粧料 |
JP2608777B2 (ja) | 1989-02-07 | 1997-05-14 | サンスター株式会社 | 美白化粧料 |
JPH0539485A (ja) | 1991-08-02 | 1993-02-19 | Kose Corp | 液晶組成物及びこれを含有する化粧料 |
DE69325935T2 (de) * | 1992-03-17 | 2000-01-20 | Eisai Co Ltd | Hautbleichendes Mittel enthaltend Teprenone |
JP2722309B2 (ja) * | 1992-05-15 | 1998-03-04 | 株式会社資生堂 | 皮膚外用剤 |
ATE182786T1 (de) | 1992-08-04 | 1999-08-15 | Rhone Poulenc Rorer Gmbh | Pharmazeutische und/oder kosmetische zubereitung |
GB2283173A (en) | 1993-10-28 | 1995-05-03 | Sansho Seiyaku Kk | Epidermal composition comprising kojic acid and an ultra-violet light absorbent |
FR2751535B1 (fr) * | 1996-07-25 | 1998-11-27 | Oreal | Utilisation de derives de la melatonine pour la la depigmentation de la peau et compositions les comprenant |
JPH10186811A (ja) | 1996-12-27 | 1998-07-14 | Konica Corp | 放電ワイヤの清掃装置 |
US6174533B1 (en) * | 1997-05-23 | 2001-01-16 | The Procter & Gamble Company | Skin care compositions and method of improving skin appearance |
US5980904A (en) * | 1998-11-18 | 1999-11-09 | Amway Corporation | Skin whitening composition containing bearberry extract and a reducing agent |
-
1997
- 1997-06-10 JP JP16959097A patent/JP3687277B2/ja not_active Expired - Lifetime
-
1998
- 1998-06-09 CN CN98808102A patent/CN1125634C/zh not_active Expired - Lifetime
- 1998-06-09 EP EP98923189A patent/EP0992236B1/en not_active Expired - Lifetime
- 1998-06-09 US US09/445,562 patent/US6669932B2/en not_active Expired - Lifetime
- 1998-06-09 TW TW087109143A patent/TW381028B/zh not_active IP Right Cessation
- 1998-06-09 WO PCT/JP1998/002548 patent/WO1998056338A1/ja active IP Right Grant
- 1998-06-09 KR KR1019997011602A patent/KR100554860B1/ko not_active IP Right Cessation
- 1998-06-09 DE DE69812948T patent/DE69812948T2/de not_active Expired - Lifetime
-
2000
- 2000-09-15 HK HK00105843A patent/HK1026376A1/xx not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101607166B1 (ko) * | 2008-10-01 | 2016-03-29 | (주)아모레퍼시픽 | 포스파티딜에탄올아민과 포스파티딜콜린을 포함한 리포좀을함유하는 피부 미백용 화장료 조성물 |
Also Published As
Publication number | Publication date |
---|---|
TW381028B (en) | 2000-02-01 |
KR20010013593A (ko) | 2001-02-26 |
HK1026376A1 (en) | 2000-12-15 |
CN1266367A (zh) | 2000-09-13 |
JPH111423A (ja) | 1999-01-06 |
WO1998056338A1 (fr) | 1998-12-17 |
DE69812948T2 (de) | 2003-11-13 |
US20030103916A1 (en) | 2003-06-05 |
EP0992236A1 (en) | 2000-04-12 |
DE69812948D1 (de) | 2003-05-08 |
EP0992236B1 (en) | 2003-04-02 |
US6669932B2 (en) | 2003-12-30 |
EP0992236A4 (en) | 2002-01-09 |
CN1125634C (zh) | 2003-10-29 |
JP3687277B2 (ja) | 2005-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100554860B1 (ko) | 미백 화장품 재료 | |
DE69300514T2 (de) | Kosmetische und/oder pharmazeutische zusammensetzung, die eine dispersion von lipidvesikeln enthält, verfahren zur herstellung besagter, und lipidvesikeldispersion. | |
RU2125443C1 (ru) | Косметическая или дерматологическая композиция для одновременного лечения поверхностных и глубоких слоев кожи и ее применение | |
JP3610983B2 (ja) | アスコルビル−ホスホリル−コレステロール | |
DE69400337T2 (de) | Mittel gegen Hautalterung, das gleichzeitig auf die Hautoberschichten und Tiefschichten wirkt | |
RU2139038C1 (ru) | Использование акцептора спинов в косметической или дерматологической композиции и косметическая или дерматологическая композиция на его основе | |
US20050232953A1 (en) | Microemulsions having a binary phase differentiability and active substance differentiability, the production thereof and their use, particularly for the topical supply of oxygen | |
JP2003119120A (ja) | リポソームの製造方法、及び該リポソームを含有する化粧料、及び皮膚外用剤 | |
FR2714600A1 (fr) | Composition protectrice, nutritive et/ou raffermissante pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation. | |
HUT71728A (en) | Slimming composition for topical treatment, containing two types of liposomes, and use thereof | |
JPH07277918A (ja) | 化粧用又は皮膚科用の組成物及びその製造法 | |
DE69937679T2 (de) | Wasserlösliche zusammensetzung enthaltend aktive inhaltsstoffe zur depigmentierung der haut | |
KR20140123295A (ko) | 투명 세라마이드 에멀젼을 함유하는 화장료 조성물 | |
KR100483391B1 (ko) | 안정화된 미백 조성물 및 이의 제조 방법 | |
JP2010180193A (ja) | 高品質化粧料 | |
JP2005179313A (ja) | 皮膚化粧料用基剤の製造方法および皮膚化粧料 | |
JP4080946B2 (ja) | 皮膚外用剤 | |
JP3807926B2 (ja) | アスコルビン酸類を含む皮膚外用剤 | |
JPH08183726A (ja) | 皮膚外用剤 | |
JP2845466B2 (ja) | ヒドロキノンとコウジ酸とを内包したリポソームと、薬学的組成物、特に皮膚明色化活性と抗炎症活性とを有する皮膚科学的組成物、またはコウジ酸とヒドロキノンとを内包したリポソームを含有する化粧用組成物とからなることを特徴とする薬学的組成物または化粧用組成物の調製に用いる活性素組成物 | |
JPH11228438A (ja) | 皮膚外用剤 | |
JPH11130615A (ja) | リポソーム分散液の製造方法及びそれを用いた化粧料 | |
JP2001072570A (ja) | 皮膚外用剤 | |
JP2006137705A (ja) | メラニン産生抑制剤及び皮膚外用剤 | |
JP2622602B2 (ja) | 水性化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130118 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140117 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150119 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160119 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170119 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180118 Year of fee payment: 13 |
|
EXPY | Expiration of term |